The story of Sildenafil presents a intricate picture for investors. While the initial release generated massive profits, the lapse of its patent opened the avenue to cheaper alternatives, dramatically diminishing https://dailybookmarkhit.com/story21730118/the-copyright-and-pharma-a-precarious-bet